BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8816752)

  • 1. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator.
    McInerney EM; Tsai MJ; O'Malley BW; Katzenellenbogen BS
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10069-73. PubMed ID: 8816752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor.
    Kraus WL; McInerney EM; Katzenellenbogen BS
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12314-8. PubMed ID: 8618892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.
    Métivier R; Penot G; Flouriot G; Pakdel F
    Mol Endocrinol; 2001 Nov; 15(11):1953-70. PubMed ID: 11682626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
    Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS
    Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
    Dutertre M; Smith CL
    Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
    Cho H; Katzenellenbogen BS
    Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.
    Bai Y; Giguére V
    Mol Endocrinol; 2003 Apr; 17(4):589-99. PubMed ID: 12554772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation.
    McInerney EM; Katzenellenbogen BS
    J Biol Chem; 1996 Sep; 271(39):24172-8. PubMed ID: 8798658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
    Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
    Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
    Lazennec G; Ediger TR; Petz LN; Nardulli AM; Katzenellenbogen BS
    Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of estrogen receptor activation of the prolactin enhancer/promoter by antagonistic activation function-2-interacting proteins.
    Schaufele F
    Mol Endocrinol; 1999 Jun; 13(6):935-45. PubMed ID: 10379892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists.
    Mahfoudi A; Roulet E; Dauvois S; Parker MG; Wahli W
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4206-10. PubMed ID: 7753783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains.
    Kobayashi Y; Kitamoto T; Masuhiro Y; Watanabe M; Kase T; Metzger D; Yanagisawa J; Kato S
    J Biol Chem; 2000 May; 275(21):15645-51. PubMed ID: 10747867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta.
    Tremblay GB; Tremblay A; Copeland NG; Gilbert DJ; Jenkins NA; Labrie F; Giguère V
    Mol Endocrinol; 1997 Mar; 11(3):353-65. PubMed ID: 9058381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo.
    Tetel MJ; Giangrande PH; Leonhardt SA; McDonnell DP; Edwards DP
    Mol Endocrinol; 1999 Jun; 13(6):910-24. PubMed ID: 10379890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human homologue of the yeast DNA repair and TFIIH regulator MMS19 is an AF-1-specific coactivator of estrogen receptor.
    Wu X; Li H; Chen JD
    J Biol Chem; 2001 Jun; 276(26):23962-8. PubMed ID: 11279242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N-terminal of the estrogen receptor (ERalpha) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells.
    Rousseau C; Pettersson F; Couture MC; Paquin A; Galipeau J; Mader S; Miller WH
    J Steroid Biochem Mol Biol; 2003 Jul; 86(1):1-14. PubMed ID: 12943740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.
    Smith CL; Nawaz Z; O'Malley BW
    Mol Endocrinol; 1997 Jun; 11(6):657-66. PubMed ID: 9171229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors alpha and beta.
    Tremblay A; Tremblay GB; Labrie C; Labrie F; Giguère V
    Endocrinology; 1998 Jan; 139(1):111-8. PubMed ID: 9421405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.